-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
O8QYyCOOtHOAsjry1itf7ElX3owDcuAmW9LWst8GvQkMdfMWhuHK8kHSlD0sCABg
FYJ4ULEYu/9c5D8Tvw3/Sg==
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 8)*
Mediware Information Systems, Inc.
(Name of Issuer)
Common Stock, par value $.10 per share
(Title of Class of Securities)
584946107
(CUSIP Number)
Mr. Lawrence E. Auriana
145 East 45th Street
New York, NY 10012
(212) 922-2999
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
January 26, 2004
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this Schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ].
NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule13d-7 for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
SCHEDULE 13D
CUSIP No. 584946107
1) NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) [ ]
(b) [X]
3) SEC USE ONLY
4) SOURCE OF FUNDS (SEE INSTRUCTIONS)
PF
5) CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
6) CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.
NUMBER OF SHARES |
7) SOLE VOTING POWER |
2,275,225 |
BENEFICIALLY OWNED |
8) SHARED VOTING POWER |
None |
BY EACH REPORTING |
9) SOLE DISPOSITIVE POWER |
2,275,225 |
PERSON WITH |
10) SHARED DISPOSITIVE POWER |
None |
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,275,225
12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES.
(SEE INSTRUCTIONS) [ ]
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
30.1%
14) TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
Lawrence E. Auriana hereby amends and supplements the Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") on August 16, 1991, as amended by Amendment No. 1 filed with the SEC on July 10, 1996, by Amendment No. 2 filed with the SEC on January 6, 2000, by Amendment No. 3 filed with the SEC on January 22, 2001, by Amendment No. 4 filed with the SEC on February 8, 2002, by Amendment No. 5 filed with the SEC on February 7, 2003, by Amendment No. 6 filed with the SEC on July 22, 2003, and as further amended by Amendment No. 7 filed with the SEC on November 7, 2003 (the "Schedule") as follows:
This Schedule relates to the common stock, par value $.10 per share ("Common Stock"), of Mediware Information Systems, Inc., a New York corporation.
Item 3. Source and Amount of Funds or Other Consideration.
Item 3 of the Schedule is hereby supplemented by inserting the following text as the last paragraph thereof:
"The purchase of the 5,000 shares of Common Stock that is the subject of Amendment
No. 8 to the Schedule were paid for with Mr. Auriana's personal funds."
Item 5. Interest in Securities of the Issuer.
Item 5(a) of the Schedule is hereby amended by deleting the existing text and inserting the following text in its stead:
"Mr. Auriana beneficially owns (as defined by Rule 13d-3 under the Securities
Exchange Act of 1934, as amended) 2,275,225 shares, or 30.1% of the shares of
Common Stock outstanding as of February 2, 2004. 93,200 of such shares are
issuable pursuant to presently exercisable options under the Company's stock
option plans."
Item 5(b) of the Schedule is hereby amended by deleting the existing text and inserting the following text in its stead:
"Mr. Auriana has sole voting and dispositive power over 2,275,225 shares of
Common Stock."
Item 5(c) of the Schedule is hereby amended by deleting the existing text and inserting the following text in its stead:
"The following chart sets forth information concerning acquisitions of
shares of Common Stock by Mr. Auriana during the past sixty (60) days:
|
Number of |
|
January 26, 2004 |
5,000 |
$13.246 |
All such shares were purchased in open market transactions."
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
/s/ Lawrence E. Auriana |
Date: February 6, 2004